Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Speciation of CuCl and CuCl2 Thiol-Amine Solutions and Characterization of Resulting Films: Implications for Semiconductor Device Fabrication.

Murria P, Miskin CK, Boyne R, Cain LT, Yerabolu R, Zhang R, Wegener EC, Miller JT, Kenttämaa HI, Agrawal R.

Inorg Chem. 2017 Nov 13. doi: 10.1021/acs.inorgchem.7b01359. [Epub ahead of print]

PMID:
29131598
2.

Dehydrogenative Transformations of Imines Using a Heterogeneous Photocatalyst.

Adolph CM, Werth J, Selvaraj R, Wegener EC, Uyeda C.

J Org Chem. 2017 Jun 2;82(11):5959-5965. doi: 10.1021/acs.joc.7b00617. Epub 2017 May 15.

PMID:
28485932
3.

Compound heterozygous variants in PGAP1 causing severe psychomotor retardation, brain atrophy, recurrent apneas and delayed myelination: a case report and literature review.

Kettwig M, Elpeleg O, Wegener E, Dreha-Kulaczewski S, Henneke M, Gärtner J, Huppke P.

BMC Neurol. 2016 May 21;16:74. doi: 10.1186/s12883-016-0602-7. Review.

4.

Patterned Polypeptoid Brushes.

Schneider M, Tang Z, Richter M, Marschelke C, Förster P, Wegener E, Amin I, Zimmermann H, Scharnweber D, Braun HG, Luxenhofer R, Jordan R.

Macromol Biosci. 2016 Jan;16(1):75-81. doi: 10.1002/mabi.201500314. Epub 2015 Nov 2.

PMID:
26524353
5.

Characterization of the MeCP2R168X knockin mouse model for Rett syndrome.

Wegener E, Brendel C, Fischer A, Hülsmann S, Gärtner J, Huppke P.

PLoS One. 2014 Dec 26;9(12):e115444. doi: 10.1371/journal.pone.0115444. eCollection 2014.

6.

Tectonic gene mutations in patients with Joubert syndrome.

Huppke P, Wegener E, Böhrer-Rabel H, Bolz HJ, Zoll B, Gärtner J, Bergmann C.

Eur J Hum Genet. 2015 May;23(5):616-20. doi: 10.1038/ejhg.2014.160. Epub 2014 Aug 13. Review.

7.

Drug-induced morphology switch in drug delivery systems based on poly(2-oxazoline)s.

Schulz A, Jaksch S, Schubel R, Wegener E, Di Z, Han Y, Meister A, Kressler J, Kabanov AV, Luxenhofer R, Papadakis CM, Jordan R.

ACS Nano. 2014 Mar 25;8(3):2686-96. doi: 10.1021/nn406388t. Epub 2014 Feb 27.

8.

MIA is a potential biomarker for tumour load in neurofibromatosis type 1.

Kolanczyk M, Mautner V, Kossler N, Nguyen R, Kühnisch J, Zemojtel T, Jamsheer A, Wegener E, Thurisch B, Tinschert S, Holtkamp N, Park SJ, Birch P, Kendler D, Harder A, Mundlos S, Kluwe L.

BMC Med. 2011 Jul 4;9:82. doi: 10.1186/1741-7015-9-82.

9.

Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model.

Brendel C, Belakhov V, Werner H, Wegener E, Gärtner J, Nudelman I, Baasov T, Huppke P.

J Mol Med (Berl). 2011 Apr;89(4):389-98. doi: 10.1007/s00109-010-0704-4. Epub 2010 Dec 1. Erratum in: J Mol Med (Berl). 2013 Jun;91(6):775.

10.

Identification of common nail and skin disorders.

Wegener EE, Johnson WR.

J Hand Ther. 2010 Apr-Jun;23(2):187-97; quiz 198. doi: 10.1016/j.jht.2009.12.002. Epub 2010 Mar 20. Review.

PMID:
20304604
11.

Dynamic protein complexes regulate NF-kappaB signaling.

Wegener E, Krappmann D.

Handb Exp Pharmacol. 2008;(186):237-59. doi: 10.1007/978-3-540-72843-6_10. Review.

PMID:
18491055
12.

Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation.

Oeckinghaus A, Wegener E, Welteke V, Ferch U, Arslan SC, Ruland J, Scheidereit C, Krappmann D.

EMBO J. 2007 Nov 14;26(22):4634-45. Epub 2007 Oct 18.

13.

MALT1 directs B cell receptor-induced canonical nuclear factor-kappaB signaling selectively to the c-Rel subunit.

Ferch U, zum Büschenfelde CM, Gewies A, Wegener E, Rauser S, Peschel C, Krappmann D, Ruland J.

Nat Immunol. 2007 Sep;8(9):984-91. Epub 2007 Jul 29.

PMID:
17660823
14.

CARD-Bcl10-Malt1 signalosomes: missing link to NF-kappaB.

Wegener E, Krappmann D.

Sci STKE. 2007 May 1;2007(384):pe21.

PMID:
17473310
15.

Parkin mediates neuroprotection through activation of IkappaB kinase/nuclear factor-kappaB signaling.

Henn IH, Bouman L, Schlehe JS, Schlierf A, Schramm JE, Wegener E, Nakaso K, Culmsee C, Berninger B, Krappmann D, Tatzelt J, Winklhofer KF.

J Neurosci. 2007 Feb 21;27(8):1868-78.

16.

Essential role for IkappaB kinase beta in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation.

Wegener E, Oeckinghaus A, Papadopoulou N, Lavitas L, Schmidt-Supprian M, Ferch U, Mak TW, Ruland J, Heissmeyer V, Krappmann D.

Mol Cell. 2006 Jul 7;23(1):13-23.

17.

The IkappaB kinase complex and NF-kappaB act as master regulators of lipopolysaccharide-induced gene expression and control subordinate activation of AP-1.

Krappmann D, Wegener E, Sunami Y, Esen M, Thiel A, Mordmuller B, Scheidereit C.

Mol Cell Biol. 2004 Jul;24(14):6488-500.

18.

Degradation of Bcl10 induced by T-cell activation negatively regulates NF-kappa B signaling.

Scharschmidt E, Wegener E, Heissmeyer V, Rao A, Krappmann D.

Mol Cell Biol. 2004 May;24(9):3860-73.

19.

Principles of internal fixation as applied to the hand and wrist.

Jabaley ME, Wegener EE.

J Hand Ther. 2003 Apr-Jun;16(2):95-104. Review. No abstract available.

PMID:
12755161
20.

Hand fracture management.

Hardy M, Wegener E.

J Hand Ther. 2003 Apr-Jun;16(2):79-80. No abstract available.

PMID:
12755159

Supplemental Content

Loading ...
Support Center